Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from telogen effluvium happens when a disturbance or imbalance causes hair to fall out prematurely.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

Telogen effluvium is a condition that causes temporary hair loss.

Telogen effluvium is a type of temporary hair loss.

A man had temporary hair loss after a spinal cord injury, with some permanent thinning remaining.

Using selenium disulfide on guinea pigs increased hair loss.

The document's conclusion cannot be provided because the document cannot be parsed.

Trichoscopy effectively differentiates Androgenetic Alopecia from Telogen Effluvium.

Hair follicle counts and ratios are helpful in diagnosing hair loss types, but should be used with other specific features for accurate diagnosis.

The supplement effectively improved hair growth and reduced hair loss safely.

Dermoscopic features can help distinguish female androgenetic alopecia from telogen effluvium and healthy controls.

Early diagnosis and personalized treatment are crucial for managing hair loss in India.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

AGA and TE can be differentiated by specific trichoscopic features, with AGA showing more variation in hair thickness in fronto-temporal areas.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Iron deficiency common in women, not always linked to hair loss; more research needed.

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Chronic hair shedding may be caused by less variation in hair growth times and might stop on its own after several years.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 infection can significantly cause temporary hair loss.

A woman's sudden hair loss was linked to her previous COVID-19 infection.

Chronic telogen effluvium is a common hair loss condition with specific characteristics and treatment options.

Critically ill patients may experience temporary hair loss after a fever.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Minoxidil treatment for hair loss can cause scalp allergy and severe hair loss.